MCL1 and cancer: In addition, type I, II and IV B cells produce MDM4, CCND1 and MCL1 proteins, which act on or bind P53, RB1 and other anti-cancer proteins55–57, and consequently decrease the activity of anti-cancer proteins, thus promoting cell survival (Figure 7E).